It was originally isolated in 1977 from the cerebral venous blood of rabbits and has since been found to be present in small amounts in human brains and plasma, with higher concentrations later in the day.3 4 It, or a similar substance, is also present at higher concentrations in human breast milk.5 Because DSIP can cross the blood-brain barrier and is easily absorbed via the gut (unusual for a peptide), some researchers have hypothesized that it may facilitate post-feeding sleep tendencies among newborns, though it remains unclear whether DSIP truly has a hand in neonate sleep-wake cycles.4 5 6 Its mechanism of action is likewise unclear, but it may have something to do with endocrine regulation
Who Benefits Most From Oral GLP-1 Therapy Oral GLP-1 medications work best for people with mild-to-moderate weight loss goals who prefer convenience and needle-free treatment, and who are committed to sustained dietary changes
Rollout: TrumpRx by year-end 2025
Ipamorelin activates the pituitary while keeping hypothalamic regulation intact
Route: Subcutaneous injection (abdomen, thighs, or upper arms)
Among more than 85,000 people with type 2 diabetes and obesity treated between 2013 and 2023 and followed for an average of nearly four years, 2,501 obesity-related cancers developed in those taking GLP-1 diabetes drugs, compared with 2,671 such cancers in those treating their diabetes with drugs from a class known as DPP-4 inhibitors